journal article·2025-10-24

Characteristics of Coassembling Nanoparticles Based on Oleanolic Acid and Glycyrrhetinic Acid/Caffeic Acid Phenethyl Ester

Juanjuan Qin, Dongshuai Shen, Min Yang, Ziwen Yuan, Xin Chen

ACS Applied Nano Materials· Volume 8· Issue 42
Publisher page

Abstract

Oleanolic acid (OA) is a bioactive natural product with excellent coassembling properties. Glycyrrhetinic acid (GA) and caffeic acid phenethyl ester (CAPE) are natural bioactive molecules with poor water solubility. Herein, we constructed coassembly nanoparticles (NPs) of GA or CAPE with OA through hydrogen bonds and hydrophobic interactions. The resulting OA-GA NPs and OA-CAPE NPs were uniform and spherical, with mass ratios of OA to GA or CAPE in the range of 9:1–5:5. Particle sizes of OA-GA NPs were in the range of 450–550 nm, while those of OA-CAPE NPs were in the range of 500–600 nm, with stronger hydrogen bonding interactions. OA-GA/CAPE NPs had a higher water solubility than their parent molecules. OA-GA/CAPE NPs at a ratio of 8:2 in aqueous solution had the best thermal stability, pH stability, and photostability, with stability retained during 7 days of storage. Coassembly improved the antioxidant properties of OA, GA, and CAPE at mass ratios of 9:1 and 8:2, and OA-CAPE NPs performed better than OA-GA NPs. Meanwhile, compared to free GA or CAPE, the release rates of GA and CAPE have been significantly enhanced after coassembling with OA during simulated gastrointestinal digestion. Furthermore, OA-CAPE NPs at a ratio of 8:2 achieved excellent synergistic enhancement of hepatoprotective bioactivity based on a carbon tetrachloride (CCl 4 )-induced hepatotoxicity model, performing better than free OA and OA-GA NPs at a ratio of 8:2. This work highlighted the potential for the application of OA in drug delivery, and it provided a complex with high hepatoprotective bioactivity based on naturally occurring active small molecules.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pharmacological Effects of Natural Compounds · Morinda citrifolia extract uses · Natural product bioactivities and synthesis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Drug Vector Construction and Application, College of Veterinary Medicine

Gansu Agricultural University

Clinical Veterinary Medicine, College of Veterinary Medicine

College of Veterinary Medicine

Chemistry and Advanced Materials, College of Science

Chinese veterinary medicine, College of Veterinary Medicine

Funding

Natural Science Foundation of Gansu Province · Central Leading Local Science and Technology Development Project · Fuxi Foundation of Gansu Agricultural University · Early stage of Major Projects from Department of Industry and Information Technology of Gansu Province

References (49)

Show source-provided references
1. 10.1021/acsami.0c1264110.1021/acsami.0c12641 ↗
2. 10.1002/tcr.20160012310.1002/tcr.201600123 ↗
3. 10.1021/acs.molpharmaceut.8b0044410.1021/acs.molpharmaceut.8b00444 ↗
4. 10.3762/bjoc.4.2410.3762/bjoc.4.24 ↗
5. 10.1016/j.foodchem.2021.13149810.1016/j.foodchem.2021.131498 ↗
6. 10.1016/j.apjtm.2016.05.01510.1016/j.apjtm.2016.05.015 ↗
7. 10.1016/j.biomaterials.2013.07.07810.1016/j.biomaterials.2013.07.078 ↗
8. 10.1211/002235705540710.1211/0022357055407 ↗
9. 10.1016/j.ajps.2015.07.00210.1016/j.ajps.2015.07.002 ↗
10. 10.1039/D0TB02071K10.1039/D0TB02071K ↗
11. 10.1016/j.foodchem.2024.13948210.1016/j.foodchem.2024.139482 ↗
12. 10.1002/ptr.236210.1002/ptr.2362 ↗
13. 10.3390/ph1605064110.3390/ph16050641 ↗
14. 10.1007/s10853-021-06396-x10.1007/s10853-021-06396-x ↗
15. 10.22038/ijbms.2020.44101.1033410.22038/ijbms.2020.44101.10334 ↗
16. 10.1016/j.biomaterials.2010.02.04210.1016/j.biomaterials.2010.02.042 ↗
17. 10.1002/med.2148410.1002/med.21484 ↗
18. 10.1021/acsami.4c1532010.1021/acsami.4c15320 ↗
19. 10.1016/j.foodchem.2021.12915410.1016/j.foodchem.2021.129154 ↗
20. 10.1016/j.ecoenv.2020.11157810.1016/j.ecoenv.2020.111578 ↗
21. 10.1016/j.foodchem.2022.13440910.1016/j.foodchem.2022.134409 ↗
22. 10.1016/j.lwt.2020.11031910.1016/j.lwt.2020.110319 ↗
23. 10.1016/j.foodhyd.2023.10887410.1016/j.foodhyd.2023.108874 ↗
24. 10.1016/j.foodres.2022.11176010.1016/j.foodres.2022.111760 ↗
25. 10.1016/j.foodhyd.2021.10685110.1016/j.foodhyd.2021.106851 ↗
26. 10.1016/j.foodchem.2007.04.06710.1016/j.foodchem.2007.04.067 ↗
27. 10.1016/j.taap.2023.11650910.1016/j.taap.2023.116509 ↗
28. 10.1016/j.bcp.2020.11423210.1016/j.bcp.2020.114232 ↗
29. 10.1021/acsami.1c2290010.1021/acsami.1c22900 ↗
30. 10.1016/j.biopha.2023.11488110.1016/j.biopha.2023.114881 ↗
31. 10.1021/acsami.9b1844310.1021/acsami.9b18443 ↗
32. 10.1016/j.lwt.2018.03.08010.1016/j.lwt.2018.03.080 ↗
33. 10.3390/pharmaceutics1409179710.3390/pharmaceutics14091797 ↗
34. 10.1016/j.jfoodeng.2019.04.01010.1016/j.jfoodeng.2019.04.010 ↗
35. 10.1134/S002689330804019510.1134/S0026893308040195 ↗
36. 10.3390/pharmaceutics1509231510.3390/pharmaceutics15092315 ↗
37. 10.3390/gels1009056910.3390/gels10090569 ↗
38. 10.1016/j.foodchem.2023.13651910.1016/j.foodchem.2023.136519 ↗
39. 10.1021/acs.cgd.6b0075910.1021/acs.cgd.6b00759 ↗
40. 10.1016/j.cocis.2013.03.00110.1016/j.cocis.2013.03.001 ↗
41. 10.1016/j.foodchem.2011.11.09110.1016/j.foodchem.2011.11.091 ↗
42. 10.1016/j.foodchem.2020.12715810.1016/j.foodchem.2020.127158 ↗
43. 10.1016/j.foodchem.2008.03.07810.1016/j.foodchem.2008.03.078 ↗
44. 10.3390/biom1309129110.3390/biom13091291 ↗
45. 10.1021/acs.jafc.8b0038810.1021/acs.jafc.8b00388 ↗
46. 10.1016/j.lwt.2021.11193810.1016/j.lwt.2021.111938 ↗
47. 10.1016/S1875-5364(20)30014-510.1016/S1875-5364(20)30014-5 ↗
48. 10.1016/j.ijbiomac.2023.12482310.1016/j.ijbiomac.2023.124823 ↗
49. 10.2147/IJN.S19665110.2147/IJN.S196651 ↗